Table 1.
The prevalence of Male versus female patients distributed on study variables.
| Ocular manifestation | % (n) |
|
|---|---|---|
| Males | Females | |
| Extraocular muscle paralysis | 0 | 100% (2) |
| Anterior uvitis | 77.8% (7) | 22.2% (2) |
| Vitritis | 70% (7) | 30% (3) |
| Retinal vasculities (vascular sheathing) | 44.4% (4) | 55.6% (5) |
| Vascular occlusion | 66.7% (2) | 33.3% (1) |
| Multifocal retinitis | 100% (2) | 0 |
| Macular edema especially cystoids type (CMO) | 66.7% (4) | 33.3% (2) |
| Epiretinal membrane (ERM) | 66.7% (4) | 33.3% (2) |
| Retinal atrophy | 0 | 100% (1) |
| Papillitis | 0 | 100% (1) |
| Optic atrophy | 50% (1) | 50% (1) |
| Papildema | 50% (1) | 50% (1) |
| Neovascularization elsewhere (NVE) | 100% (1) | 0 |